Safety and immunogenicity of HBAI20 Hepatitis B vaccine in healthy naive and nonresponding adults
Version 2 2024-06-04, 06:22
Version 1 2019-05-17, 10:14
journal contribution
posted on 2024-06-04, 06:22 authored by OM Koc, PHM Savelkoul, IHM van Loo, Anna PeetersAnna Peeters, AML Oude LashofSafety and immunogenicity of HBAI20 Hepatitis B vaccine in healthy naive and nonresponding adults
History
Journal
JOURNAL OF VIRAL HEPATITISVolume
25Pagination
1048-1056Location
EnglandOpen access
- Yes
Link to full text
ISSN
1352-0504eISSN
1365-2893Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2018, The AuthorsIssue
9Publisher
WILEYUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineGastroenterology & HepatologyInfectious DiseasesVirologyadjuvantHBAI20Hepatitis BimmunogenicitynonrespondersafetyvaccineCONTROLLED CLINICAL-TRIALCHRONIC UREMIC PATIENTSLOW-DOSE INTERLEUKIN-2T-CELL-ACTIVATIONRECOMBINANT INTERLEUKIN-2DENDRITIC CELLSSURFACE-ANTIGENINFLUSOME-VACDIFFERENTIATIONEFFICACY3204 Immunology
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC